SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-300336
Filing Date
2018-10-16
Accepted
2018-10-16 17:05:59
Documents
4
Period of Report
2018-10-12
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d624473d8k.htm 8-K 34214
2 EX-3.1 d624473dex31.htm EX-3.1 7620
3 EX-3.2 d624473dex32.htm EX-3.2 4707
4 EX-23.1 d624473dex231.htm EX-23.1 2130
  Complete submission text file 0001193125-18-300336.txt   50197
Mailing Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010
Business Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 181124931
SIC: 2834 Pharmaceutical Preparations